ARCHIVES

FDA Likely To Change Procedures For Patient Interaction, Official Says

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

Triple-Negative Breast Cancer Equally Aggressive in Whites

February 25, 2011

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011